German Biotech Database

News in the Life Sciences Industry
Results 1 - 20 out of 410 displayed.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 »

European Commission approves Aubagio® (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis

By: GlobenewsWire - 18 Jun 2021

BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-based BNT111 in Patients with Advanced Melanoma

By: GlobenewsWire - 18 Jun 2021

Related companies: BioNTech SE

atai Life Sciences Announces Pricing of Upsized Initial Public Offering

By: GlobenewsWire - 18 Jun 2021

Related companies: ATAI Life Sciences AG

Gilead Sciences Announces Subanalyses of Safety and Efficacy Data from a Phase 2 Study of Chronic Hepatitis B Patients with Renal or Hepatic Impairment Switching to Vemlidy(r)

-- Data Presented at the Global Hepatitis Summit Show that Virally Suppressed Patients from Taiwan with Renal or Hepatic Impairment had High Rates of Viral Suppression and Improved or Stable Bone and Renal Parameters, Following Switching to Vemlidy® -- Read more ››

By: PR Newswire Association LLC. - 18 Jun 2021

Roche Expands Partnership With Ghana Ministry of Health to Improve Cancer Care, Opening First of Three New Cancer Centres at Cape Coast Teaching Hospital

Geographic barriers restrict access to cancer treatment; Roche's partnership with the government will work to improve oncology services at hospitals across the country and launch three new cancer treatment centres in 2021. The first cancer treatment centre was launched today at the Cape Coast Teaching... Read more ››

By: PR Newswire Association LLC. - 17 Jun 2021

Two U.S. Researchers Win European Inventor Award 2021

- Chemist Sumita Mitra wins European Patent Office innovation prize for her pioneering use of nanotechnology in dentistry;- Columbia University Professor Gordana Vunjak-Novakovic receives most votes in online poll to take home the Popular Prize for her work in biomedical engineering Read more ››

By: PR Newswire Association LLC. - 17 Jun 2021

InflaRx to Present at the Raymond James Human Health Innovation Conference

By: GlobenewsWire - 17 Jun 2021

Related companies: InflaRx N.V.

CENTOGENE Reports First Quarter 2021 Financial Results in the Lead Up to Virtual Investor Event

By: GlobenewsWire - 16 Jun 2021

Related companies: Centogene N.V.

Dr. David S. Wilkes Appointed to Syneos Health Board of Directors

By: GlobenewsWire - 16 Jun 2021

Affimed Announces Appointment of Uta Kemmerich-Keil to its Supervisory Board

By: GlobenewsWire - 16 Jun 2021

Related companies: Affimed N.V

Berlin-based Cantourage provides Fast Track Access to the European medical cannabis market for international cultivators

- European cannabis company Cantourage launches a new platform enabling cannabis cultivators from across the world to enter the EU/UK market swiftly and reliably.;- Cantourage guarantees compliance to highest European quality standards for all products on its platform and developed and implemented... Read more ››

By: PR Newswire Association LLC. - 16 Jun 2021

French National Healthcare System Adopts Exclusive Reimbursement Policy for SI-BONE, Inc.’s iFuse-3D Implant System™

By: GlobenewsWire - 15 Jun 2021

Establishing TAVR for the Treatment of Aortic Regurgitation(1)

By: GlobenewsWire - 15 Jun 2021

Related companies: JenaValve Technology GmbH | JenaValve Technology Inc.

Medcare Hospitals & Medical Centres Advances Digital Transformation Initiative with Capsule

By: PR Newswire Association LLC. - 15 Jun 2021

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 14 Jun 2021

CEBINA announces the launch of Danube Labs, a partnership with Evotec to develop cutting edge biotechnology projects sourced from Central and Eastern European Universities and Research Institutions

By: PR Newswire Association LLC. - 14 Jun 2021

Related companies: Evotec SE

Bridge Biotherapeutics Announces the Initiation of Patient Dosing in the Proof of Clinical Principle Study for BBT-401, an Investigational Drug for Ulcerative Colitis

- The Phase IIa, proof of clinical principle study, had its first patient dosed in the USA;- A new drug formulation is expected to improve target organ drug delivery and distribution;- The new formulation of BBT-401 demonstrated greater drug recovery in the colon and ileum via the in vitro SHIME®... Read more ››

By: PR Newswire Association LLC. - 14 Jun 2021

atai Life Sciences Announces Launch of Initial Public Offering

By: GlobenewsWire - 11 Jun 2021

Related companies: ATAI Life Sciences AG

New pivotal data at EHA 2021 reinforces sutimlimab as a first-in-class investigational C1s inhibitor with the potential to be the first approved treatment for hemolysis in people with CAD, a serious and chronic autoimmune hemolytic anemia

By: GlobenewsWire - 11 Jun 2021

Ocean Biomedical, Inc. Files Registration Statement For Proposed Initial Public Offering

By: GlobenewsWire - 10 Jun 2021

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 »

Looking for companies outside of Germany?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.